We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.72B
AUM Growth
+$377M
Cap. Flow
-$47.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.31%
Holding
1,615
New
130
Increased
604
Reduced
665
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 10.88%
3 Healthcare 10.31%
4 Consumer Discretionary 9.37%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVD icon
201
First Trust Value Line Dividend Fund
FVD
$8.33B
$6.66M 0.12%
154,676
-2,270
-1% -$93.9K
FND icon
202
Floor & Decor
FND
$5.98B
$6.64M 0.12%
51,046
+551
+1% +$71K
DGRO icon
203
iShares Core Dividend Growth ETF
DGRO
$42.8B
$6.61M 0.12%
118,940
+2,880
+2% +$154K
XRT icon
204
State Street SPDR S&P Retail ETF
XRT
$453M
$6.59M 0.12%
+72,987
New +$6.88M
BN icon
205
Brookfield
BN
$103B
$6.58M 0.12%
202,107
-4,349
-2% -$138K
FCN icon
206
FTI Consulting
FCN
$4.95B
$6.56M 0.11%
42,758
-200
-0.5% -$29.2K
TJX icon
207
TJX Companies
TJX
$176B
$6.55M 0.11%
86,290
+8,890
+11% +$617K
CME icon
208
CME Group
CME
$96.1B
$6.49M 0.11%
28,416
+53
+0.2% +$11.7K
GPN icon
209
Global Payments
GPN
$23.8B
$6.45M 0.11%
47,730
+19,765
+71% +$2.73M
NTR icon
210
Nutrien
NTR
$33.9B
$6.45M 0.11%
85,722
+35,873
+72% +$2.51M
MOAT icon
211
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$6.43M 0.11%
84,519
+14,379
+21% +$1.09M
CBSH icon
212
Commerce Bancshares
CBSH
$8.55B
$6.39M 0.11%
113,082
+100
+0.1% +$5.63K
XLY icon
213
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$6.36M 0.11%
62,252
+27,810
+81% +$2.77M
NEAR icon
214
iShares Short Maturity Bond ETF
NEAR
$4.83B
$6.33M 0.11%
126,658
-1,237
-1% -$61.9K
NVAX icon
215
Novavax
NVAX
$1.22B
$6.32M 0.11%
44,150
+14,197
+47% +$2.44M
OBDC icon
216
Blue Owl Capital
OBDC
$5.36B
$6.23M 0.11%
439,831
+25,318
+6% +$362K
FBIN icon
217
Fortune Brands Innovations
FBIN
$5.88B
$6.21M 0.11%
68,007
+465
+0.7% +$40.2K
TROW icon
218
T. Rowe Price
TROW
$25.6B
$6.18M 0.11%
31,427
-2,558
-8% -$520K
MKC icon
219
McCormick & Company Non-Voting
MKC
$13.7B
$6.13M 0.11%
63,417
+8,017
+14% +$683K
SYK icon
220
Stryker
SYK
$133B
$6.13M 0.11%
22,905
+2,015
+10% +$529K
D icon
221
Dominion Energy
D
$61.3B
$6.12M 0.11%
77,962
-1,375
-2% -$103K
BIL icon
222
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$6.08M 0.11%
66,440
+50,577
+319% +$4.62M
IWM icon
223
iShares Russell 2000 ETF
IWM
$80.2B
$6.01M 0.11%
27,031
+759
+3% +$172K
HUM icon
224
Humana
HUM
$44B
$6M 0.1%
12,936
-807
-6% -$357K
CIBR icon
225
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.1B
$5.95M 0.1%
112,725
+40,617
+56% +$2.13M

Similar funds

Oppenheimer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer & Co held 1,615 positions worth $5.72B, up 7.1% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q4 2021 filing shows 130 new, 604 increased, 665 reduced and 130 closed positions. Its largest new stake was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M. The largest sale was Global X S&P 500 Covered Call ETF, an estimated $49.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q4 2021 buy was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M.
  • Oppenheimer & Co added most to Canadian Pacific Kansas City in Q4 2021, an estimated $7.48M increase.
  • Oppenheimer & Co's biggest Q4 2021 reduction was Global X S&P 500 Covered Call ETF, cutting an estimated $49.9M.
  • Oppenheimer & Co fully exited Kansas City Southern in Q4 2021, selling an estimated $6.61M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.72B portfolio in Q4 2021.
  • Oppenheimer & Co opened 130 new positions and closed 130 in Q4 2021.
  • Oppenheimer & Co's portfolio value rose 7.1% quarter-over-quarter to $5.72B.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.